A trial looking at veliparib and chemotherapy for all types of non small cell lung cancer except squamous cell cancer

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Phase 3

Details

This trial is comparing a new drug called veliparib alongside chemotherapy with standard chemotherapy for non small cell lung cancer (NSCLC). It is for people with all types of NSCLC, except squamous cell cancer. Their cancer has spread into the surrounding area or to other parts of the body. This is called advanced NSCLC.

Recruitment start: 30 April 2015

Recruitment end: 30 June 2016